Abbott Resolves 2022 Infant Formula Claims Through DOJ Deal
Abbott Park, Illinois, September 14, 2026 Abbott has reached an agreement with the U.S. Department of Justice (DOJ) and...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Abbott Park, Illinois, September 14, 2026 Abbott has reached an agreement with the U.S. Department of Justice (DOJ) and...
Scottsdale, Arizona, August 19, 2026 Allure Beauty Concepts has converted its Scottsdale facility into a fully FDA-registered, cGMP-compliant over-the-counter...
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
COPENHAGEN, Denmark, August 12, 2026 Novonesis announced the launch of Optiva® Triticum, a new biosolution designed to help pasta...
WASHINGTON, D.C., July 22, 2026 The U.S. Food and Drug Administration (FDA) has announced two significant regulatory actions aimed...
CHICAGO, March 2, 2026 Conagra Brands, Inc. announced it will release its fiscal 2026 third quarter earnings results on...
